OPPI appoints Anil Matai as Director-General

October 16, 2023 | Monday | News

His proven skill-sets in operations leadership, collaborative working, stakeholder management, have contributed towards market-leading results

The Organisation of Pharmaceutical Producers of India (OPPI), which represents global research-based pharmaceutical companies, has appointed Anil Matai as its Director General (DG).

Matai, a seasoned general management professional, has extensive experience in the life sciences space having worked across MNCs including spearheading operations across Novartis India, GSK India, and Global Pharma, Dubai.

After superannuating as Managing Director of Zydus Healthcare, Matai was engaged as Senior Advisor - Life Sciences at IQVIA Consulting and Information Services India, and most recently as Operating Partner at Jashvik Capital - a mid-market Private Equity Fund focused on Healthcare & Consumer sector.

He has functioned on the boards of Zydus Healthcare, Bayer Zydus Pharma, Novartis Healthcare and Biochem Pharmaceutical Industries.

As an influential leader, his proven skillsets in operations leadership, collaborative working, stakeholder management, have contributed towards market-leading results. He has championed multi-million-dollar businesses and is proficient in unlocking company value by successfully executing growth strategies, institutionalising controls, and enhancing productivity.

Comments

× Your session has expired. Please click here to Sign-in or Sign-up

Have an Account?

Forgot your password?

First Name should not be empty!

Last Name should not be empty!

Email address should not be empty!

Show Password should not be empty!

Show Confirm Password should not be empty!

Newsletter

E-magazine

Biospectrum Infomercial

Bio Resource

I accept the terms & conditions & Privacy policy